Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd announced at its Annual General Meeting that Richard, the founding Managing Director, will retire in early 2026 after 25 years with the company. The recruitment process for his successor is well underway, ensuring a smooth leadership transition. The company acknowledged Richard’s significant contributions and the promising future opportunities for Proteomics International.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, a subsidiary of PILL, is a medical technology company based in Perth, Western Australia. It specializes in precision diagnostics and bio-analytical services, focusing on proteomics, which involves the large-scale study of protein structures and functions. The company’s mission is to enhance the quality of life through innovative tools that improve disease treatment.
Average Trading Volume: 288,090
Technical Sentiment Signal: Sell
Current Market Cap: A$52.38M
See more data about PIQ stock on TipRanks’ Stock Analysis page.